Complexities of glucuronidation affecting in vitro in vivo extrapolation.

Abstract:

:Glucuronidation is responsible for the clearance of a diverse range of drug and chemicals whose topology confers properties that complicate in vitro-in vivo clearance correlations as compared to those possible for oxidative metabolism. The active site of the UGTs faces the inside of the luminal space of the endoplasmic reticulum, thus presenting diffusional barriers for substrates, the cosubstrate, UDPGA, and resultant glucuronide products. Transport processes for the cosubstrate UDPGA and glucuronidated products likely contribute to the well-known latency phenomena in which exogenous detergents or alamethicin are required for maximal UGT activity in microsomes. This complicates the extrapolation of results of in vitro clearance studies to the in vivo situation. Even with activation, the microsomal-based clearance values still underestimate the actual in vivo UGT-mediated clearance; therefore latency is not the only explanation for the poor correlation. Recent data indicate that hepatocytes are a promising in vitro system that can be used for the early evaluation of human clearance behavior of drug candidates. Both induction and inhibition of UGT-mediated clearance are a source of clinical drug-drug interactions. Emerging evidence indicates that the same mechanisms identified in the regulation of CYP enzymes also are involved in regulation of the UGTs, i.e., CAR, AH and probably PXR mediate regulation of UGT1A1, 1A6 and UGT2B7, respectively. In contrast to CYP-mediated interactions, with a few exceptions, the magnitude of UGT-mediated interactions are less than 2-fold because of the relatively high UGT Km values and substrate overlap among the multiple isozymes.

journal_name

Curr Drug Metab

journal_title

Current drug metabolism

authors

Lin JH,Wong BK

doi

10.2174/1389200023336992

keywords:

subject

Has Abstract

pub_date

2002-12-01 00:00:00

pages

623-46

issue

6

eissn

1389-2002

issn

1875-5453

journal_volume

3

pub_type

杂志文章,评审
  • Cytochrome P450 4A fatty acid omega hydroxylases.

    abstract::The Cytochrome P450 4A subfamily is one of eighteen subfamilies in the CYP4 family and presently consists of twenty individual forms in nine different mammalian species. The major substrates for CYP4A forms are fatty acids, but recent studies have shown other non-fatty acid substrates may be metabolized by specific CY...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200013338423

    authors: Okita RT,Okita JR

    更新日期:2001-09-01 00:00:00

  • NF-kappa B signature on the aging wall.

    abstract::During the lifetime, our cells encounter many challenges to their own existence. The survival of organisms and cells depends on the interplay within a complex, yet precisely orchestrated network of proteins. Since the discovery of the Rel/NF-kappaB family of transcription factors, the research has never come to a stop...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920010791196283

    authors: Zineldeen DH,Uranishi H,Okamoto T

    更新日期:2010-03-01 00:00:00

  • The role of protein plasticity in computational rationalization studies on regioselectivity in testosterone hydroxylation by cytochrome P450 BM3 mutants.

    abstract::Recently, it was found that mutations in the binding cavity of drug-metabolizing Cytochrome P450 BM3 mutants can result in major changes in regioselectivity in testosterone (TES) hydroxylation. In the current work, we report the intrinsic reactivity of TES' C-H bonds and our attempts to rationalize experimentally obse...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920012798918471

    authors: de Beer SB,van Bergen LA,Keijzer K,Rea V,Venkataraman H,Guerra CF,Bickelhaupt FM,Vermeulen NP,Commandeur JN,Geerke DP

    更新日期:2012-02-01 00:00:00

  • Characterization of an etoposide-glutathione conjugate derived from metabolic activation by human cytochrome p450.

    abstract::Etoposide (VP-16), a DNA topoisomerase II poison widely used as an antineoplastic agent is also known to cause leukemia. One of its major metabolic pathways involves O-demethylation to etoposide catechol (etoposide-OH) by cytochrome P450 3A4 (CYP3A4). The catechol metabolite can undergo sequential one- and two-electro...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920006779010638

    authors: Zheng N,Pang S,Oe T,Felix CA,Wehrli S,Blair IA

    更新日期:2006-12-01 00:00:00

  • Comparison of cytochrome P450 2D6 and variants in terms of drug oxidation rates and substrate inhibition.

    abstract::This review focuses on identification of the important active site residues of CYP2D6 in terms of CYP2D6 polymorphism. A meta-analysis was performed on the reported literature regarding (1) values of the Michaelis-Menten constant (K(m)), maximal velocity (V(max)), and intrinsic clearance (V(max)/K(m)) for 41 metabolic...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,meta分析,评审

    doi:10.2174/138920011795495286

    authors: Niwa T,Murayama N,Yamazaki H

    更新日期:2011-06-01 00:00:00

  • Age-related changes in pharmacokinetics.

    abstract::Ageing is characterized by a progressive decline in the functional reserve of multiple organs and systems, which can influence drug disposition. In addition, comorbidity and polypharmacy are highly prevalent in the elderly. As ageing is associated with some reduction in first-pass metabolism, bioavailability of a few ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920011796504527

    authors: Shi S,Klotz U

    更新日期:2011-09-01 00:00:00

  • Herb-Drug Interactions and Hepatotoxicity.

    abstract:BACKGROUND:In recent times, herbals or phytomedicines have become very popular due to their global acceptance as a complementary and alternative remedy. While modern drugs are commercially available only after laboratory validations, clinical trials, as well as approval from drug regulatory authorities, majority of the...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200220666190325141422

    authors: Parvez MK,Rishi V

    更新日期:2019-01-01 00:00:00

  • Impact of various factors on pharmacokinetics of bioactive polyphenols: an overview.

    abstract::Several epidemiological studies throughout the years have suggested that polyphenols from fruits and vegetables promote health and reduce the risk of certain chronic and neurodegenerative diseases. Yet, it has been proved to be extremely difficult to quantitatively establish the benefit afforded by polyphenols, princi...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200214666131210144115

    authors: Rubió L,Macià A,Motilva MJ

    更新日期:2014-01-01 00:00:00

  • Clonetics.

    abstract::Work on human immortalized cell lines is not considered research on human subjects, but does involve biohazards. It has also been estimated that about 80% of human cell lines are the kind of cells that they are expected. Cells that are cultured directly from a subject are referred to as primary cells. Clonetics is the...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920008783884768

    authors: Gomase VS,Tagore S,Changbhale SS,Kale KV

    更新日期:2008-03-01 00:00:00

  • Modulation and absorption of xenobiotics: the synergistic role of CYP450 and P-gp activities in cancer and neurodegenerative disorders.

    abstract::P-glycoprotein (P-gp) is involved in MDR and in neurodegenerative disorders such as Parkinson disease (PD), Alzheimer disease (AD) and epilepsy. Cytochrome P450 enzymes (CYP450s) catalyze the metabolism of a wide variety of endogenous and exogenous compounds including xenobiotics, drugs, environmental toxins, steroids...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920011798357015

    authors: Inglese C,Perrone MG,Berardi F,Perrone R,Colabufo NA

    更新日期:2011-10-01 00:00:00

  • Has the Time Come to Employ Population and Individual Bioequivalence for the Evaluation of Generics?

    abstract:BACKGROUND:Bioequivalence studies are a vital part of drug development. The average bioequivalence approach is the standard method of assessment to conclude whether the generic product is bioequivalent to the innovator product. Of late, debates are on whether the average bioequivalence approach adequately addresses dru...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,随机对照试验

    doi:10.2174/1389200221666200401105119

    authors: Micheal F,Sayana M,Prasad R,Motilal BM

    更新日期:2020-01-01 00:00:00

  • Recent Developments of Magnetic Nanoparticles for Theranostics of Brain Tumor.

    abstract:BACKGROUND:Glioblastoma multiforme, one of the most aggressive brain tumors, has a very poor clinical outcome. Despite the introduction of the alkylating reagent temozolomide (TMZ) to surgery and radiotherapy, the survival of patients could only be modestly increased up to less than 15 months. Therefore, innovative tre...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200217666160607232540

    authors: Shevtsov M,Multhoff G

    更新日期:2016-01-01 00:00:00

  • Atypical antipsychotic metabolism and excretion.

    abstract:BACKGROUND:The metabolic/biotransformation pathways of atypical antipsychotics (aripiprazole, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone) have been characterized and reviewed. However, comparisons of excretory pathways remain unexplored. OBJECTIVE:To analyze the excretio...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920010791636202

    authors: Sheehan JJ,Sliwa JK,Amatniek JC,Grinspan A,Canuso CM

    更新日期:2010-07-01 00:00:00

  • Helix-Coil Transition Signatures B-Raf V600E Mutation and Virtual Screening for Inhibitors Directed Against Mutant B-Raf.

    abstract:BACKGROUND:Mutation in the B RAF at V600E has been well implicated in the carcinogenesis that makes it as an attractive therapeutictarget. In the present study, we sought to identify the basis of V600E mutation at functional and structural grounds. The study also endeavors in identification of small molecule as a poten...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200218666170503114611

    authors: Bandaru S,Sumithnath TG,Sharda S,Lakhotia S,Sharma A,Jain A,Hussain T,Nayarisseri A,Singh SK

    更新日期:2017-07-21 00:00:00

  • Physiologically-Based Pharmacokinetic (PBPK) Modelling of Transporter Mediated Drug Absorption, Clearance and Drug-Drug Interactions.

    abstract::Membrane transporters play an important role in intestinal absorption, distribution and clearance of drugs. Additionally transporters along with enzymes regulate tissue exposures (e.g. liver, kidney and brain), which are important for safety and efficacy considerations. Early identification of transporters involved gu...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200221999210101233340

    authors: Taskar KS,Harada I,Alluri RV

    更新日期:2021-01-01 00:00:00

  • Hepatotoxicity and tumorigenicity induced by metabolic activation of pyrrolizidine alkaloids in herbs.

    abstract::In the recent decades, the use of herbal products has been rapidly growing in the Western countries. While their use in many cases causes adverse effects, to date, safety issues of herbal products have not been adequately addressed. It is rarely determined whether the non-purported bioactive constituents in the herbs ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920011797470119

    authors: Li N,Xia Q,Ruan J,Fu PP,Lin G

    更新日期:2011-11-01 00:00:00

  • Preclinical Pharmacokinetics Study of a Novel Intravenous Anesthetic ET-26 Hydrochloride.

    abstract:BACKGROUND:ET-26 hydrochloride is a novel intravenous anesthetic, approved for clinical trials, that produces a desirable sedative-hypnotic effect with stable myocardial performance and mild adrenocortical suppression in rats and beagle dogs. The objective of this study was to assess the absorption, distribution, metab...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/1389200221666191223105504

    authors: Zhang YJ,Deng C,Yang J,Gong D,Kang Y,Liu J,Zhang W

    更新日期:2019-01-01 00:00:00

  • Curcumin - A Novel Therapeutic Agent in the Prevention of Colorectal Cancer.

    abstract:BACKGROUND:Colorectal cancer is the third important cause of cancer-associated deaths across the world. Hence, there is an urgent need for understanding the complete mechanism associated with colorectal cancer, which in turn can be utilized toward early detection as well as the treatment of colorectal cancer in humans....

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200220666191007153238

    authors: Gupta MK,Vadde R,Sarojamma V

    更新日期:2019-01-01 00:00:00

  • Cholinesterase reactivators: the fate and effects in the organism poisoned with organophosphates/nerve agents.

    abstract::Understanding the mechanism of action of organophosphates (OP)/nerve agents -- irreversible acetylcholinesterase (AChE, EC 3.1.1.7) inhibition at the cholinergic synapses followed by metabolic dysbalance of the organism -- two therapeutic principles for antidotal treatment are derived. The main drugs are anticholinerg...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920007782798144

    authors: Bajgar J,Kuca K,Jun D,Bartosova L,Fusek J

    更新日期:2007-12-01 00:00:00

  • Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodies.

    abstract::With the advances in recombinant DNA biotechnology, molecular biology and immunology, the number of biotech drugs, including peptides, proteins and monoclonal antibodies, available for clinical use has dramatically increased in recent years. Although pharmacokinetic principles are equally applicable to the large molec...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920009789895499

    authors: Lin JH

    更新日期:2009-09-01 00:00:00

  • UDP-glucuronosyltransferases.

    abstract::Glucuronidation represents a major pathway which enhances the elimination of many lipophilic xenobiotics and endobiotics to more water-soluble compounds. The UDP-glucuronosyltransferase (UGT) family catalyzes the glucuronidation of the glycosyl group of a nucleotide sugar to an acceptor compound (aglycone) at a nucleo...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200003339171

    authors: King CD,Rios GR,Green MD,Tephly TR

    更新日期:2000-09-01 00:00:00

  • Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

    abstract::5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) belongs to a group of naturally-occurring psychoactive indolealkylamine drugs. It acts as a nonselective serotonin (5-HT) agonist and causes many physiological and behavioral changes. 5-MeO-DMT is O-demethylated by polymorphic cytochrome P450 2D6 (CYP2D6) to an active metab...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920010794233495

    authors: Shen HW,Jiang XL,Winter JC,Yu AM

    更新日期:2010-10-01 00:00:00

  • Active metabolites resulting from decarboxylation, reduction and ester hydrolysis of parent drugs.

    abstract::Decarboxylation, reduction and hydrolysis can yield active metabolites from the parent drug. Major therapeutic indications and metabolic routes of these drugs are reviewed. Changes in the logP values (determined and calculated) from the parent drug to the active metabolite show certain characteristics in comparison to...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920012800840437

    authors: Hartyánszky I,Kalász H,Adeghate E,Gulyás Z,Hasan MY,Tekes K,Adem A,Sótonyi P

    更新日期:2012-07-01 00:00:00

  • Nanotechnology-based Drug Delivery, Metabolism and Toxicity.

    abstract:BACKGROUND:Nanoparticles (NPs) are being used extensively owing to their increased surface area, targeted delivery and enhanced retention. NPs have the potential to be used in many disease conditions. Despite widespread use, their toxicity and clinical safety still remain a major concern. OBJECTIVE:The purpose of this...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200221666200103091753

    authors: Malaviya P,Shukal D,Vasavada AR

    更新日期:2019-01-01 00:00:00

  • Metabolism and disposition of the antiviral nucleoside analogue AM365 in the isolated perfused rat liver.

    abstract::The present study was designed to investigate the hepatic disposition of the prodrug AM365 and the generated antiviral guanosine analogue, AM188 in the isolated perfused rat liver (IPL). The livers of rats (n=12) were isolated and perfused with Krebs-Henseleit pH 7.4 buffer to which AM365 was added as a bolus to achie...

    journal_title:Current drug metabolism

    pub_type: 杂志文章

    doi:10.2174/138920005774330611

    authors: Wang J,Nation RL,Evans AM,Cox S,Shackleford D

    更新日期:2005-10-01 00:00:00

  • Optimization of Drugs Pharmacotherapy During Pregnancy Using Physiologically Based Pharmacokinetic Models - An Update.

    abstract:BACKGROUND:Clinical studies during pregnancy are rare due to ethical and practical limitations. Giving pregnant females the same dosing regimen used in adult males or nonpregnant females is inappropriate. Pregnancy physiologically-based pharmacokinetic modeling is a powerful tool that can be used to refine pharmacother...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180702104034

    authors: Alsmadi MM,Idkaidek N

    更新日期:2018-01-01 00:00:00

  • Effects of dietary broccoli on human in vivo caffeine metabolism: a pilot study on a group of Jordanian volunteers.

    abstract:OBJECTIVES:Induction or inhibition of cytochrome P450 (CYP) enzyme activities, enzymes that activate or detoxify xenobiotics, is one mechanism by which vegetables may alter cancer risk. As the effect of food on CYP enzyme activities have not been studied in the Jordanian population, we examined the effect of supplement...

    journal_title:Current drug metabolism

    pub_type: 临床试验,杂志文章

    doi:10.2174/138920007779315080

    authors: Hakooz N,Hamdan I

    更新日期:2007-01-01 00:00:00

  • The impact of in vitro binding on in vitro-in vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactions.

    abstract::This review provides a vista of the current opportunities and remaining challenges in the area of in vitro-in vivo extrapolation, with particular emphasis on drug binding terms in predictive models, which has been the source of much controversy. Although the importance of fu(inc) (fraction unbound in in vitro incubati...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920006776359266

    authors: Grime K,Riley RJ

    更新日期:2006-04-01 00:00:00

  • Review of and perspectives on the toxicology of graphene-based materials.

    abstract::Graphene possesses a wide range of potential biomedical applications because of the unique physical and chemical properties. However, the side effects of grapheme and its derivatives on a number of biological models even on human body are still not very clear. Therefore, to properly assess the potential risk of graphe...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/138920021131400108

    authors: Xu C,Wang J,Xu Y,Shang G,Wang R,Lin Y

    更新日期:2013-10-01 00:00:00

  • A Review of Theranostics Applications and Toxicities of Carbon Nanomaterials.

    abstract:BACKGROUND:In the last few years, the use of modified Carbon Nanomaterials (CNMs) for theranostics (therapeutic and diagnosis) applications is a new and rapidly growing area in pharmacy and medical fields. Owing to this, their specific physicochemical behaviors like high stability, drug loading, surface area to volume ...

    journal_title:Current drug metabolism

    pub_type: 杂志文章,评审

    doi:10.2174/1389200219666180925094515

    authors: Gupta N,Rai DB,Jangid AK,Kulhari H

    更新日期:2019-01-01 00:00:00